|
News and Events > Newsletters > Monthly Newsletter: November/December 2004
University of Colorado Technology Transfer Office
Monthly Newsletter
Volume 1 ~ Issue 4 ~ November/December 2004
Top Stories
TTO Announces Third Annual Technology Transfer Awards Winners
The University of Colorado Technology Transfer Office (TTO) held its third annual awards ceremony November 8 to celebrate CU inventors, licensee companies and advisors who have assisted the TTO. The awards were created to honor the best practice technology licensing arrangements that are advancing the university's objective of moving technology into the public sector. (more)
TTO Hosts Invention to Venture Inventor's Conference
The TTO and the University License Equity Holdings, Inc. (ULEHI) recently held an educational program featuring speaker presentations and panel discussions of entrepreneurship fundamentals, the University licensing process, tips from successful faculty and business people, and fundraising methods. The full day program was held at the Discovery Learning Center on CU Boulder's campus and drew close to 100 attendees. The participants ranged from faculty and students interested in technology commercialization to business professionals interested in participating in the university commercialization process. The curriculum for the workshop was provided by the National Collegiate Inventors and Innovators Alliance (NCIIA) and the TTO, and delivered by CU faculty and Front Range business leaders.
The 'Invention to Venture' program was made possible through contributions from the primary event sponsors: The NCIIA and Holme Roberts & Owen, LLP, and secondary sponsors the Colorado Leeds School of Business, Silicon Flatirons Telecommunications Program, Colorado Venture Capital Association, and w3w3 Media Network. (more)
Today at the TTO
TTO Hires Life Science Licensing Associate
In November TTO expanded its Life Sciences licensing staff by hiring Mary Tapolsky, Ph.D. Dr. Tapolsky has a doctorate in biological chemistry from the University of North Carolina at Chapel Hill (1989). Her past experience includes ten years in academic and industrial research and development. Dr. Tapolsky spent six years in France, working at Ecole Polytechnique and Ecole Normale Superieure de Lyon. Subsequently, she worked at Introgen Therapeutics in Houston before relocating to Colorado with her family in 1999. She will manage life sciences inventions, patenting and licensing opportunities arising from all three CU campuses. Her office is at 4001 Discovery Drive and she can be reached at 303-735-2298 or Mary.Tapolsky@colorado.edu.
Competitive Technologies Licenses CU Technology To Bayer
Competitive Technologies, Inc. (CTT) and Bayer HealthCare, announced recently that they have settled the patent case relating to homocysteine medical tests. CTT managed certain intellectual property for CU in the 1980's and CU maintains a financial interest in the new license. (more)
TTO in the News
NIST Inventors' Work Highlighted in Discover Magazine
In a recent R&D article, Discover Magazine highlighted the work of John Kitching, Svenja Knappe, and Li-Anne Liew on a miniature atomic clock the size of a grain of rice which is believed to have tremendous potential in future efforts to maintain temporal continuity across large systems. (more)
Denver Post: Technology Transfer Awards
The University of Colorado's Technology Transfer Office recognized a lineup of scientists, venture capitalists and spinoff companies at its third annual awards banquet Monday. But an extra reason for celebration was the $5.8 million in revenue generated for the university this past fiscal year through technology royalties and the liquidations of CU's holdings in four spinoff companies. (more)
Denver Post: Cheek, Spritz, and Burns Weigh in on The Importance of Biotechnology
Recently, Colorado was ranked among the top 10 states for the impact its biotech and pharmaceutical industries have on the state's economy. The Milken Institute recognized Colorado for its strength in biotech research and development, building blocks of the biotech revolution. (more)
CU Inventor's Research Discussed in Recent Edition of Cell
CU inventors from the Health Sciences Center Department of Biochemistry and Molecular Genetics were published in the online journal Cell recently. Their paper describes Mechanisms of Conformational Change for a Replicative Hexameric Helicase of SV40 Large Tumor Antigen. (more)
Spotlight On:
| CU Boulder's Technology of the Month |
CU HSC's Technology of the Month |
CU's Company of the Month |
| CU1240B - Network Protocol for Content Based Networking in Sensor Networks |
CU1230H - Novel Nanogel Materials and Methods of Use Thereof |
Barofold |
| Wireless sensor networks are increasingly used to transmit data for homeland security, health care, factory production, transportation and weather prediction, among other applications. However, wireless transmission is still power-intensive and sensors are constrained by limited battery life. New technologies are needed to ensure that data is transmitted in the most efficient manner. Cyrus Hall, Dr. Antonio Carzaniga and their colleagues in the Department of Computer Science at University of Colorado at Boulder have developed a new networking protocol for wireless sensor networks that requires fewer wireless transmissions. |
Nanogels are essentially hyper-branched polymer molecules whose finite size distinguishes them from crosslinked polymer networks. The latter are characterized as "infinite" macroscopic interconnected molecules which are, by definition, insoluble in all solvents. Nanogel polymeric particles are typically soluble in common solvents that dissolve analogous linear polymers. The highly-branched architecture of nanogel molecules offer the advantage of less viscous solutions than are possible with linear polymers at similar concentrations. |
BaroFold, Inc. is a private biotechnology company with a proprietary method (US patent #6,489,450) of producing proteins at lower costs and higher yields with a safer final product. The technology involves the use of high hydrostatic pressure to disaggregate and refold proteins. The method is simple, reliable, and can operate on an industrial scale using commercially available equipment. In addition to partner proteins, BaroFold has established the feasibility of high hydrostatic pressure technology for IVIg (Intravenous Immunoglobulin), hGH (human Growth Hormone), and G-CSF (Granulocyte Colony Stimulating Factor). At this point, BaroFold has multiple agreements with major pharmaceutical and biotechnology companies for the use of high pressure in the research and development efforts within these companies. (more) |
Search our database for licenseable CU Technologies
Technology Transfer Bulletin of the Month
The U.S. Patent Process
The CU TTO identifies the steps in the U.S. patenting process, including the need for provisional patent protection and a timeline of patent processing at the USPTO.
|
Upcoming Events
TTO Legal Seminar: A Primer on Patents
The CU Technology Transfer Office and the law offices of Holme, Roberts & Owen present the TTO Legal Seminar: "A Primer on Patents" with David Seely of Holme, Roberts & Owen. (more)
TTO Legal Seminar: Obtaining Technology and Rights from University Technology Transfer Offices -- Critical Issues for both Universities and Companies
The CU Technology Transfer Office, the law offices of Holme, Roberts & Owen, and LeftHand Networks present the TTO Legal Seminar: "Obtaining Technology and Rights from University Technology Transfer Offices -- Critical Issues for both Universities and Companies" with David Seely of Holme, Roberts & Owen. (more)
Innovation in the News
Judge Halts Patent Suits Against Columbia
A federal judge in Boston dismissed patent claims filed by large biotechnology companies against Columbia University that alleged the New York school was improperly trying to extend its rights to a process widely used to engineer new drugs.
Biotech in Stem Cell Giveaway
A Melbourne biotech company will offer scientists unconditional access to a new embryonic stem-cell line in an effort to speed up lifesaving medical research. Stem Cell Sciences says it is the first time a human embryonic stem-cell line has been made freely available to researchers worldwide, without any commercial or intellectual property constraints.
Where Have All the Blockbusters Gone?
Analysts argue the recent pharmaceutical model of relying on a few blockbuster drugs to spur profit and growth will not work much longer. They argue companies will have to change the way they market drugs and will shift away from widely popular compounds and focus instead on smaller targeted drugs with small markets.
Stem-Cell Victory Powers UCSF Expansion Plan
The University of California at San Francisco is expected to aggressively expand its stem-cell research program, advancing plans for a new $65M stem-cell facility following the passage of Proposition 71.
Tech Transfer's Living Legacy
Howard Bremer, whose career has tracked with and influenced the development of university technology transfer initiatives, reflects on his path and where it has led both him and the evolving debate over use of federally funded inventions.
Funny Science Gets Its Reward
Researchers who patented a comb-over hairstyle in 1975 were top prize winners in the engineering section of this year's Ig Nobel awards. Father and son team Frank and Donald Smith developed a method to cover partial baldness using only the individual's own hair.
|
